Results 21 to 30 of about 11,040 (158)
Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
Conditional survival accounts for the time already survived after surgery and may be of additional informative value. A nomogram was constructed that predicts 5‐year survival of patients with oesophageal cancer after neoadjuvant treatment followed by surgery, based on cardiac co‐morbidity, cN category, ypTN stage, chyle leakage and pulmonary ...
E. R. C. Hagens +6 more
wiley +1 more source
Impact of postoperative complications on survival after oesophagectomy for oesophageal cancer
Recent evidence suggests that complications following oesophagectomy may decrease short‐ and long‐term survival. In this study, Clavien–Dindo grade II and IV complications decreased overall and recurrence‐free survival in univariable and multivariable Cox regression analyses.
J. R. Bundred +5 more
wiley +1 more source
Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery
A nationwide prospective register‐based study examined the extent of lymphadenectomy in curative gastric cancer surgery and its effects on long‐term survival. More evidence in favour of thorough lymphadenectomy Background Gastrectomy including D2 lymphadenectomy is regarded as the standard curative treatment for advanced gastric cancer in Asia.
C.‐H. Kung +5 more
wiley +1 more source
The neutrophil to lymphocyte ratio, dichotomized at 2·25, was strongly associated with Mandard tumour regression grade in patients who had neoadjuvant chemotherapy for oesophageal adenocarcinoma. The systemic inflammatory response may offer a novel therapeutic target for patients at risk of poor response.
A. G. M. T. Powell +6 more
wiley +1 more source
UEG Week 2021 Moderated Posters
United European Gastroenterology Journal, Volume 9, Issue S8, Page 163-259, October 2021.
wiley +1 more source
Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study
After oesophagectomy for oesophageal adenocarcinoma (OAC), the 5‐year survival rate is currently only 30 per cent. There is strong observational evidence that statin use is associated with reduced all‐cause and cancer‐specific mortality in patients with OAC.
L. Alexandre +16 more
wiley +1 more source
Expresión de regiones organizadoras nucleolares en epitelio de mucosa de esófago y estómago en ratones CF-1 expuestos a 4-nitroquinolina-1-oxido y ratones no expuestos [PDF]
79 p.INTRODUCCIÓN: A nivel mundial, el cáncer de esófago y estómago ocupan el sexto y cuarto lugar respectivamente entre las neoplasias más comunes. En el estudio del cáncer, los modelos de carcinogénesis experimental en animales, acordes al medio local,
Elizalde Ramírez, María de los Angeles +1 more
core
Objectives Repeated endoscopic ultrasound (EUS)‐guided tissue acquisition represents the standard practice for solid pancreatic lesions after previous nondiagnostic or inconclusive results. Since data are lacking, we aimed to evaluate the diagnostic performance of repeated EUS fine‐needle biopsy (rEUS‐FNB) in this setting.
Andrea Lisotti +76 more
wiley +1 more source
Intubación en el cáncer de esófago
Presentado en sesión de 20 de abril de ...
Félix E Leborgne, Luis A Barlocci
doaj
Perfil dos Pacientes com Câncer de Esôfago Diagnosticados entre 2001 e 2010 no Brasil
Introdução: O câncer de esôfago é a terceira neoplasia mais comum do trato digestivo e apresenta prognóstico ruim quando diagnosticado em estádios avançados da doença. Objetivo: Descrever as características sociodemográficas, clínicas e de tratamento dos
Ariane Igreja Buccos Marinho Cruz +3 more
doaj +1 more source

